SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001626199-19-000014
Filing Date
2019-03-18
Accepted
2019-03-18 16:39:53
Documents
3
Effectiveness Date
2019-03-18

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_20190319xevergreen.htm S-8 134473
2 EXHIBIT 5.1 alpn-ex51_20190318xevergre.htm EX-5.1 7602
3 EXHIBIT 23.1 alpn-ex231_20190318xevergr.htm EX-23.1 2961
  Complete submission text file 0001626199-19-000014.txt   146234
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230369 | Film No.: 19688749
SIC: 2834 Pharmaceutical Preparations